Works matching DE "HER2 gene"
Results: 892
Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique.
- Published in:
- European Journal of Health Economics, 2014, v. 15, n. 1, p. 93, doi. 10.1007/s10198-013-0459-2
- By:
- Publication type:
- Article
HER2 Amplification and Overexpression Is Not Present in Pediatric Osteosarcoma: A Tissue Microarray Study.
- Published in:
- Pediatric & Developmental Pathology, 2005, v. 8, n. 5, p. 525, doi. 10.1007/s10024-005-0044-5
- By:
- Publication type:
- Article
Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.
- Published in:
- Bioinformatics, 2015, v. 31, n. 22, p. 3666, doi. 10.1093/bioinformatics/btv377
- By:
- Publication type:
- Article
Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion.
- Published in:
- Bioinformatics, 2014, v. 30, n. 21, p. 3036, doi. 10.1093/bioinformatics/btu400
- By:
- Publication type:
- Article
Quantitative Measurement of HER2/neu Oncogene Amplification and p53 Tumor Suppressor Gene Deletion by RT-PCR in Breast Cancer.
- Published in:
- Experimed, 2023, v. 13, n. 3, p. 257, doi. 10.26650/experimed.1374959
- By:
- Publication type:
- Article
In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Triple negative breast cancer: Pitfalls and progress.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00468-0
- By:
- Publication type:
- Article
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-021-00376-9
- By:
- Publication type:
- Article
Evolution of HER2-low expression from primary to recurrent breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00343-4
- By:
- Publication type:
- Article
Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer.
- Published in:
- Turkish Journal of Medical Sciences, 2017, v. 47, n. 6, p. 1791, doi. 10.3906/sag-1702-152
- By:
- Publication type:
- Article
Problem-solving Test: Real-time Polymerase Chain Reaction.
- Published in:
- Biochemistry & Molecular Biology Education, 2009, v. 37, n. 4, p. 250
- By:
- Publication type:
- Article
Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.
- Published in:
- ANZ Journal of Surgery, 2018, v. 88, n. 10, p. 982, doi. 10.1111/ans.14773
- By:
- Publication type:
- Article
HER2 基因突变对非小细胞肺癌临床特征及其与 CT 征象的相关性研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 12, n. 24, p. 4646, doi. 10.13241/j.cnki.pmb.2020.24.010
- By:
- Publication type:
- Article
Functional analysis of a putative HER2-associated expressed enhancer, Her2-Enhancer1, in breast cancer cells.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46460-x
- By:
- Publication type:
- Article
Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization images.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36811-z
- By:
- Publication type:
- Article
Overexpression of HER2/neu in solid tumours: an immunohistochemical survey.
- Published in:
- Histopathology, 2001, v. 38, n. 2, p. 96, doi. 10.1046/j.1365-2559.2001.01084.x
- By:
- Publication type:
- Article
Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use.
- Published in:
- Histopathology, 2000, v. 37, n. 5, p. 411, doi. 10.1046/j.1365-2559.2000.00984.x
- By:
- Publication type:
- Article
HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation.
- Published in:
- Case Reports in Oncological Medicine, 2013, p. 1, doi. 10.1155/2013/234391
- By:
- Publication type:
- Article
Par6–aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control.
- Published in:
- Nature Cell Biology, 2006, v. 8, n. 11, p. 1235, doi. 10.1038/ncb1485
- By:
- Publication type:
- Article
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results.
- Published in:
- Animals (2076-2615), 2024, v. 14, n. 18, p. 2625, doi. 10.3390/ani14182625
- By:
- Publication type:
- Article
Protective Effect of HER2 Gene Polymorphism rs24537331 in the Outcome of Canine Mammary Tumors.
- Published in:
- Animals (2076-2615), 2023, v. 13, n. 8, p. 1384, doi. 10.3390/ani13081384
- By:
- Publication type:
- Article
Labeling and Biological Evaluation of <sup>99m</sup>Tc-HYNIC-Trastuzumab as a Potential Radiopharmaceutical for In Vivo Evaluation of HER2 Expression in Breast Cancer.
- Published in:
- World Journal of Nuclear Medicine, 2013, v. 12, n. 1, p. 27, doi. 10.4103/1450-1147.113953
- By:
- Publication type:
- Article
Internal Quality Assurance Program for ERBB2 (HER2) Testing Improves the Selection of Breast Cancer Patients for Treatment with Trastuzumab.
- Published in:
- Pathology Research International, 2012, p. 1, doi. 10.1155/2012/261857
- By:
- Publication type:
- Article
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Monitoring Src status after dasatinib treatment in HER2+ breast cancer with <sup>89</sup>Zr-trastuzumab PET imaging.
- Published in:
- 2018
- By:
- Publication type:
- journal article
New drugs for breast cancer.
- Published in:
- British Medical Bulletin, 2010, v. 96, n. 1, p. 111, doi. 10.1093/bmb/ldq029
- By:
- Publication type:
- Article
Drug-Diagnostic Co-Development in Cancer.
- Published in:
- Pharmaceutical Medicine, 2010, v. 24, n. 6, p. 363, doi. 10.1007/BF03256837
- By:
- Publication type:
- Article
An ERBB3/ ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 3, p. 408, doi. 10.1111/pcmr.12089
- By:
- Publication type:
- Article
Correction: Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A study of HER2 expression in endometrial carcinoma: a single centre experience.
- Published in:
- Pan African Medical Journal, 2021, v. 38, p. 1, doi. 10.11604/pamj.2021.38.200.19978
- By:
- Publication type:
- Article
Not quite pharmacogenomics.
- Published in:
- Nature Biotechnology, 1998, v. 16, n. 13, p. 1295, doi. 10.1038/4244
- By:
- Publication type:
- Article
Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients.
- Published in:
- Mediators of Inflammation, 2016, p. 1, doi. 10.1155/2016/3239167
- By:
- Publication type:
- Article
HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers.
- Published in:
- American Journal of Clinical Pathology, 2023, v. 159, n. 5, p. 464, doi. 10.1093/ajcp/aqac179
- By:
- Publication type:
- Article
Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks.
- Published in:
- American Journal of Clinical Pathology, 2017, v. 148, n. 3, p. 199, doi. 10.1093/AJCP/AQX063
- By:
- Publication type:
- Article
HER2 Gene Protein Assay Is 1Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer.
- Published in:
- American Journal of Clinical Pathology, 2017, v. 147, n. 1, p. 89, doi. 10.1093/AJCP/AQW211
- By:
- Publication type:
- Article
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Inconsistent Results With Different Secondary Reflex Assays for Resolving HER2 Status.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reflex Repeat HER2 Testing of Grade 3 Breast Carcinoma at Excision Using Immunohistochemistry and In Situ Analysis: Frequency of HER2 Discordance and Utility of Core Needle Biopsy Parameters to Refine Case Selection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.
- Published in:
- American Journal of Clinical Pathology, 2015, v. 144, n. 2, p. 278, doi. 10.1309/AJCPIXUYDVZ0RZ3G
- By:
- Publication type:
- Article
Dual HER2 Gene Protein Assay.
- Published in:
- American Journal of Clinical Pathology, 2015, v. 143, n. 3, p. 451, doi. 10.1309/AJCPKIVVW4OBPX6I
- By:
- Publication type:
- Article
Pathologic Diagnostics of HER2 Positivity in Gastroesophageal Adenocarcinoma.
- Published in:
- American Journal of Clinical Pathology, 2015, v. 143, n. 2, p. 257, doi. 10.1309/AJCPCX69HGDDGYCQ
- By:
- Publication type:
- Article
HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer.
- Published in:
- American Journal of Clinical Pathology, 2014, v. 142, n. 6, p. 755, doi. 10.1309/AJCPIRL4GUVGK3YX
- By:
- Publication type:
- Article
HER2 Testing of Multifocal Invasive Breast Carcinoma.
- Published in:
- American Journal of Clinical Pathology, 2013, v. 140, n. 4, p. 588, doi. 10.1309/AJCPZSV2W1CPGRJW
- By:
- Publication type:
- Article
Distinguishing Score 0 From Score 1+ in HER2 Immunohistochemistry-Negative Breast Cancer.
- Published in:
- American Journal of Clinical Pathology, 2013, v. 140, n. 4, p. 561, doi. 10.1309/AJCP4A7KTAYHZSOE
- By:
- Publication type:
- Article
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 9, p. 1445, doi. 10.1038/bjc.2015.127
- By:
- Publication type:
- Article
Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 5, p. 912, doi. 10.1038/bjc.2014.641
- By:
- Publication type:
- Article
HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 10, p. 1888, doi. 10.1038/bjc.2014.388
- By:
- Publication type:
- Article